Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PLRX

PLRX News

Newswire

07:46

Pliant Therapeutics shares surge 13.64% premarket after interim trial shows tumor responses with PLN-101095 in ICI-refractory cancers.

07:36

Pliant Therapeutics Reports Promising Interim Data for PLN-101095.

10:14

Idiopathic Pulmonary Fibrosis Market Growth Driven by Next-Gen Therapies and Targeted Treatments

14:33

RBC Capital Lowers Pliant Therapeutics PT to $2 from $3.

07:47

JP Morgan downgrades Pliant Therapeutics to Underweight from Neutral.

View More

About PLRX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More